| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastric Bypass | 24 | 2023 | 812 | 3.060 |
Why?
|
| Obesity | 52 | 2023 | 12705 | 2.790 |
Why?
|
| Bariatric Surgery | 25 | 2023 | 940 | 2.750 |
Why?
|
| Weight Loss | 31 | 2023 | 2604 | 2.640 |
Why?
|
| Obesity, Morbid | 18 | 2023 | 1204 | 1.620 |
Why?
|
| Anti-Obesity Agents | 4 | 2023 | 215 | 1.350 |
Why?
|
| Gastrointestinal Tract | 4 | 2017 | 814 | 0.770 |
Why?
|
| Body Weight | 12 | 2020 | 4664 | 0.740 |
Why?
|
| Energy Metabolism | 10 | 2018 | 2896 | 0.690 |
Why?
|
| Glucagon-Like Peptide 1 | 3 | 2023 | 334 | 0.680 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2022 | 2195 | 0.640 |
Why?
|
| Anastomosis, Roux-en-Y | 3 | 2013 | 87 | 0.620 |
Why?
|
| Social Stigma | 2 | 2020 | 698 | 0.580 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2015 | 44 | 0.530 |
Why?
|
| Duodenum | 3 | 2016 | 483 | 0.520 |
Why?
|
| Liver Diseases | 4 | 2014 | 1252 | 0.500 |
Why?
|
| Appetite Depressants | 3 | 2018 | 110 | 0.490 |
Why?
|
| Bile Acids and Salts | 2 | 2014 | 353 | 0.490 |
Why?
|
| Behavior Therapy | 2 | 2019 | 866 | 0.470 |
Why?
|
| Preventive Health Services | 1 | 2019 | 575 | 0.470 |
Why?
|
| Chromosomes, Human, Pair 15 | 3 | 2013 | 374 | 0.450 |
Why?
|
| Sialyltransferases | 1 | 2013 | 75 | 0.450 |
Why?
|
| Blood Glucose | 7 | 2018 | 6249 | 0.430 |
Why?
|
| Medical Records | 1 | 2018 | 1413 | 0.430 |
Why?
|
| Disclosure | 1 | 2018 | 736 | 0.420 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2012 | 129 | 0.400 |
Why?
|
| Postprandial Period | 1 | 2013 | 292 | 0.400 |
Why?
|
| Intestinal Absorption | 2 | 2012 | 420 | 0.400 |
Why?
|
| Energy Intake | 6 | 2017 | 2147 | 0.390 |
Why?
|
| Homeostasis | 5 | 2015 | 3335 | 0.380 |
Why?
|
| Postoperative Period | 5 | 2017 | 1839 | 0.370 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 657 | 0.370 |
Why?
|
| Diabetes Mellitus | 4 | 2022 | 5724 | 0.360 |
Why?
|
| Intra-Abdominal Fat | 2 | 2012 | 591 | 0.360 |
Why?
|
| Genes, Neurofibromatosis 1 | 1 | 2010 | 79 | 0.360 |
Why?
|
| Diabetes Mellitus, Type 2 | 18 | 2023 | 11695 | 0.360 |
Why?
|
| Metagenome | 1 | 2013 | 417 | 0.350 |
Why?
|
| Calcium, Dietary | 1 | 2011 | 527 | 0.330 |
Why?
|
| Codon, Nonsense | 1 | 2010 | 281 | 0.330 |
Why?
|
| Micronutrients | 1 | 2011 | 375 | 0.330 |
Why?
|
| Gastroenterology | 2 | 2021 | 534 | 0.320 |
Why?
|
| Internship and Residency | 2 | 2018 | 5774 | 0.320 |
Why?
|
| Body Mass Index | 19 | 2023 | 12695 | 0.310 |
Why?
|
| Insurance, Health, Reimbursement | 2 | 2017 | 395 | 0.310 |
Why?
|
| Gastric Mucosa | 1 | 2011 | 598 | 0.310 |
Why?
|
| Diseases in Twins | 1 | 2010 | 450 | 0.310 |
Why?
|
| Insulin Resistance | 5 | 2018 | 3861 | 0.310 |
Why?
|
| Chromosome Aberrations | 3 | 2013 | 1811 | 0.310 |
Why?
|
| Endoscopy, Gastrointestinal | 4 | 2017 | 859 | 0.300 |
Why?
|
| Stomach | 1 | 2011 | 697 | 0.290 |
Why?
|
| Consensus | 6 | 2023 | 2935 | 0.280 |
Why?
|
| Polymorphism, Single Nucleotide | 16 | 2019 | 15494 | 0.280 |
Why?
|
| Endoscopy, Digestive System | 1 | 2009 | 345 | 0.280 |
Why?
|
| Adiposity | 2 | 2013 | 1806 | 0.270 |
Why?
|
| Genome-Wide Association Study | 14 | 2019 | 12220 | 0.270 |
Why?
|
| Humans | 115 | 2023 | 742088 | 0.270 |
Why?
|
| Intestines | 2 | 2014 | 1923 | 0.270 |
Why?
|
| Eating | 5 | 2013 | 1535 | 0.260 |
Why?
|
| Referral and Consultation | 1 | 2018 | 3527 | 0.260 |
Why?
|
| Students, Medical | 1 | 2018 | 1858 | 0.260 |
Why?
|
| Insulin | 4 | 2016 | 6575 | 0.250 |
Why?
|
| Diet | 7 | 2017 | 7923 | 0.250 |
Why?
|
| Neurofibromatosis 1 | 1 | 2010 | 562 | 0.250 |
Why?
|
| Peptide Hormones | 1 | 2005 | 134 | 0.240 |
Why?
|
| Forms and Records Control | 1 | 2005 | 160 | 0.240 |
Why?
|
| Male | 67 | 2023 | 349538 | 0.230 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2023 | 59 | 0.230 |
Why?
|
| Receptors, Glucagon | 1 | 2023 | 92 | 0.220 |
Why?
|
| Fenfluramine | 2 | 2015 | 60 | 0.220 |
Why?
|
| Bacteria | 1 | 2014 | 2102 | 0.220 |
Why?
|
| Glucose | 2 | 2012 | 4391 | 0.220 |
Why?
|
| Receptors, Opioid, mu | 3 | 2012 | 182 | 0.220 |
Why?
|
| Hepacivirus | 3 | 1999 | 1372 | 0.220 |
Why?
|
| Benzazepines | 2 | 2018 | 326 | 0.220 |
Why?
|
| Intestine, Small | 1 | 2008 | 1243 | 0.210 |
Why?
|
| Liver | 6 | 2011 | 7470 | 0.210 |
Why?
|
| Motor Activity | 2 | 2011 | 2714 | 0.210 |
Why?
|
| Gastrointestinal Diseases | 2 | 2014 | 1167 | 0.210 |
Why?
|
| Critical Illness | 2 | 2011 | 2665 | 0.200 |
Why?
|
| Peptides | 6 | 1992 | 4392 | 0.200 |
Why?
|
| Adult | 42 | 2023 | 213712 | 0.200 |
Why?
|
| Glucose Tolerance Test | 3 | 2016 | 1150 | 0.200 |
Why?
|
| Nocardia | 2 | 1991 | 10 | 0.200 |
Why?
|
| Hormones | 2 | 2023 | 884 | 0.190 |
Why?
|
| Preoperative Period | 2 | 2013 | 546 | 0.190 |
Why?
|
| Hepatitis C | 3 | 1999 | 1582 | 0.190 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2010 | 576 | 0.190 |
Why?
|
| Implants, Experimental | 2 | 2012 | 104 | 0.190 |
Why?
|
| Feces | 3 | 2013 | 1394 | 0.190 |
Why?
|
| Middle Aged | 38 | 2019 | 213127 | 0.180 |
Why?
|
| Endocannabinoids | 1 | 2020 | 116 | 0.180 |
Why?
|
| Pituitary Gland, Anterior | 2 | 1990 | 177 | 0.170 |
Why?
|
| Endpoint Determination | 2 | 2013 | 600 | 0.170 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2012 | 8300 | 0.170 |
Why?
|
| Female | 58 | 2023 | 379592 | 0.170 |
Why?
|
| Animals | 32 | 2021 | 168561 | 0.170 |
Why?
|
| Intensive Care Units | 2 | 2011 | 3679 | 0.170 |
Why?
|
| Monitoring, Physiologic | 2 | 2015 | 1737 | 0.170 |
Why?
|
| Cohort Studies | 12 | 2021 | 40450 | 0.160 |
Why?
|
| Multifactorial Inheritance | 3 | 2019 | 1190 | 0.160 |
Why?
|
| Hexokinase | 1 | 1999 | 125 | 0.160 |
Why?
|
| Calcium | 1 | 2011 | 5753 | 0.160 |
Why?
|
| Quantitative Trait Loci | 3 | 2019 | 2015 | 0.160 |
Why?
|
| Proteins | 5 | 1999 | 6096 | 0.160 |
Why?
|
| Vitamin D | 1 | 2011 | 3211 | 0.160 |
Why?
|
| Sympathetic Nervous System | 1 | 2020 | 514 | 0.150 |
Why?
|
| Interferons | 2 | 1999 | 704 | 0.150 |
Why?
|
| Viral Nonstructural Proteins | 1 | 1999 | 241 | 0.150 |
Why?
|
| Critical Pathways | 1 | 2021 | 475 | 0.150 |
Why?
|
| Comprehensive Health Care | 1 | 2018 | 127 | 0.150 |
Why?
|
| Ghrelin | 3 | 2011 | 266 | 0.150 |
Why?
|
| Peptide Fragments | 3 | 2016 | 5095 | 0.150 |
Why?
|
| Rats | 11 | 2012 | 24265 | 0.140 |
Why?
|
| Kidney | 2 | 2022 | 7167 | 0.140 |
Why?
|
| Knee Injuries | 1 | 2021 | 490 | 0.140 |
Why?
|
| Linear Models | 3 | 2013 | 5948 | 0.140 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2019 | 544 | 0.140 |
Why?
|
| Ribonucleoproteins | 1 | 1999 | 381 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 8 | 2016 | 21821 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 5 | 2023 | 7276 | 0.130 |
Why?
|
| Serotonin 5-HT2 Receptor Agonists | 1 | 2015 | 38 | 0.130 |
Why?
|
| RNA, Viral | 3 | 1999 | 2899 | 0.130 |
Why?
|
| Gene Expression Profiling | 5 | 2012 | 9410 | 0.130 |
Why?
|
| Fatty Liver | 3 | 2014 | 728 | 0.130 |
Why?
|
| Dyslipidemias | 2 | 2015 | 848 | 0.130 |
Why?
|
| Signal Transduction | 3 | 2016 | 23387 | 0.130 |
Why?
|
| Health Care Costs | 3 | 2017 | 3203 | 0.130 |
Why?
|
| Cholesterol, HDL | 4 | 2015 | 1813 | 0.130 |
Why?
|
| Remission Induction | 3 | 2018 | 2384 | 0.120 |
Why?
|
| RNA Polymerase II | 1 | 1999 | 550 | 0.120 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2015 | 1573 | 0.120 |
Why?
|
| Leptin | 7 | 2003 | 1593 | 0.120 |
Why?
|
| Heterozygote | 2 | 2012 | 2790 | 0.120 |
Why?
|
| Investigational New Drug Application | 1 | 2013 | 6 | 0.120 |
Why?
|
| Pleural Effusion, Malignant | 1 | 1995 | 101 | 0.120 |
Why?
|
| Cartilage, Articular | 1 | 2021 | 1095 | 0.120 |
Why?
|
| Life Style | 3 | 2017 | 3824 | 0.120 |
Why?
|
| Isoenzymes | 1 | 1999 | 1725 | 0.120 |
Why?
|
| Body Height | 2 | 2010 | 1574 | 0.120 |
Why?
|
| Cardiac Tamponade | 1 | 1995 | 173 | 0.120 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2023 | 711 | 0.120 |
Why?
|
| Genotype | 7 | 2011 | 12946 | 0.110 |
Why?
|
| Satiety Response | 1 | 2013 | 49 | 0.110 |
Why?
|
| Mitosporic Fungi | 1 | 1992 | 20 | 0.110 |
Why?
|
| Hepatitis D | 1 | 1993 | 18 | 0.110 |
Why?
|
| Hydrogels | 1 | 2018 | 723 | 0.110 |
Why?
|
| Receptors, LDL | 1 | 2015 | 475 | 0.110 |
Why?
|
| Waist-Hip Ratio | 2 | 2012 | 517 | 0.110 |
Why?
|
| Organic Anion Transporters | 1 | 2013 | 100 | 0.110 |
Why?
|
| Sodium Chloride | 1 | 2015 | 625 | 0.110 |
Why?
|
| Aquaporins | 1 | 2013 | 174 | 0.110 |
Why?
|
| Cryoglobulinemia | 1 | 1992 | 87 | 0.110 |
Why?
|
| Biological Therapy | 1 | 2013 | 138 | 0.100 |
Why?
|
| Citrus | 1 | 2011 | 41 | 0.100 |
Why?
|
| Hypoglycemic Agents | 4 | 2018 | 2866 | 0.100 |
Why?
|
| Treatment Outcome | 11 | 2023 | 62966 | 0.100 |
Why?
|
| Pleural Effusion | 1 | 1995 | 338 | 0.100 |
Why?
|
| Triglycerides | 3 | 2015 | 2450 | 0.100 |
Why?
|
| Gene Regulatory Networks | 2 | 2011 | 1707 | 0.100 |
Why?
|
| Exercise Test | 2 | 1998 | 2075 | 0.100 |
Why?
|
| Pain | 4 | 2012 | 4961 | 0.100 |
Why?
|
| Mice | 12 | 2020 | 81045 | 0.100 |
Why?
|
| Decision Support Techniques | 1 | 2021 | 1952 | 0.100 |
Why?
|
| Peptide Synthases | 1 | 1991 | 80 | 0.100 |
Why?
|
| Streptomyces | 1 | 1991 | 89 | 0.100 |
Why?
|
| Food, Formulated | 1 | 2011 | 109 | 0.100 |
Why?
|
| Pipecolic Acids | 1 | 1991 | 76 | 0.100 |
Why?
|
| Models, Animal | 3 | 2017 | 2170 | 0.100 |
Why?
|
| Genetic Loci | 2 | 2010 | 2572 | 0.100 |
Why?
|
| Gene Expression Regulation | 8 | 2011 | 12071 | 0.090 |
Why?
|
| Uracil | 1 | 1991 | 164 | 0.090 |
Why?
|
| Food, Fortified | 1 | 2011 | 191 | 0.090 |
Why?
|
| Weight Gain | 2 | 2011 | 2282 | 0.090 |
Why?
|
| Double-Blind Method | 5 | 2023 | 12017 | 0.090 |
Why?
|
| Environment | 2 | 2011 | 1115 | 0.090 |
Why?
|
| Molecular Sequence Data | 6 | 2012 | 18112 | 0.090 |
Why?
|
| Phentermine | 1 | 2010 | 33 | 0.090 |
Why?
|
| Probiotics | 1 | 2014 | 351 | 0.090 |
Why?
|
| Diethylstilbestrol | 1 | 1990 | 89 | 0.090 |
Why?
|
| Ephedrine | 1 | 2010 | 54 | 0.090 |
Why?
|
| Cholesterol, LDL | 3 | 2015 | 2354 | 0.090 |
Why?
|
| Algorithms | 3 | 2017 | 13853 | 0.090 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 2699 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 4 | 1998 | 7153 | 0.090 |
Why?
|
| Cyclobutanes | 1 | 2010 | 59 | 0.090 |
Why?
|
| Endocrinology | 1 | 2016 | 443 | 0.090 |
Why?
|
| Galanin | 4 | 1991 | 44 | 0.090 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 1991 | 213 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 1999 | 1899 | 0.090 |
Why?
|
| Analgesia | 2 | 2005 | 459 | 0.090 |
Why?
|
| Gastroscopes | 1 | 2009 | 19 | 0.090 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2012 | 782 | 0.090 |
Why?
|
| TCF Transcription Factors | 1 | 2009 | 140 | 0.090 |
Why?
|
| Thymidine Kinase | 1 | 1989 | 290 | 0.090 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1991 | 648 | 0.080 |
Why?
|
| Surgical Stomas | 1 | 2009 | 43 | 0.080 |
Why?
|
| Calorimetry, Indirect | 1 | 2009 | 183 | 0.080 |
Why?
|
| Caloric Restriction | 1 | 2011 | 302 | 0.080 |
Why?
|
| Lipase | 1 | 2011 | 315 | 0.080 |
Why?
|
| Risk Factors | 13 | 2021 | 72145 | 0.080 |
Why?
|
| Area Under Curve | 1 | 2013 | 1653 | 0.080 |
Why?
|
| Lymphoma, AIDS-Related | 2 | 2001 | 84 | 0.080 |
Why?
|
| Hypotension | 1 | 1995 | 880 | 0.080 |
Why?
|
| Omentum | 1 | 2009 | 170 | 0.080 |
Why?
|
| Postoperative Care | 3 | 2016 | 1484 | 0.080 |
Why?
|
| Lung Diseases | 2 | 1998 | 1884 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2019 | 17400 | 0.080 |
Why?
|
| Twins, Monozygotic | 1 | 2010 | 458 | 0.080 |
Why?
|
| Injections, Intraperitoneal | 1 | 2008 | 424 | 0.080 |
Why?
|
| Prolactin | 1 | 1990 | 669 | 0.080 |
Why?
|
| Postoperative Complications | 3 | 2016 | 15244 | 0.080 |
Why?
|
| Pituitary Gland | 1 | 1991 | 665 | 0.080 |
Why?
|
| Suture Techniques | 1 | 2013 | 797 | 0.080 |
Why?
|
| Antifungal Agents | 1 | 1992 | 729 | 0.080 |
Why?
|
| Epidemics | 1 | 2014 | 521 | 0.080 |
Why?
|
| Bupropion | 1 | 2010 | 303 | 0.080 |
Why?
|
| Absorptiometry, Photon | 1 | 2014 | 1726 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 1213 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2014 | 1533 | 0.080 |
Why?
|
| Naltrexone | 1 | 2010 | 307 | 0.080 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2011 | 794 | 0.080 |
Why?
|
| Chromosome Mapping | 4 | 2010 | 4742 | 0.080 |
Why?
|
| Longitudinal Studies | 4 | 2019 | 13921 | 0.080 |
Why?
|
| Gastroscopy | 1 | 2009 | 206 | 0.080 |
Why?
|
| Tacrolimus | 1 | 1991 | 741 | 0.080 |
Why?
|
| Base Sequence | 4 | 2010 | 12797 | 0.070 |
Why?
|
| Lactones | 1 | 2010 | 329 | 0.070 |
Why?
|
| Hepatitis B | 1 | 1993 | 695 | 0.070 |
Why?
|
| Neurotransmitter Agents | 1 | 2011 | 647 | 0.070 |
Why?
|
| Amino Acid Sequence | 4 | 2012 | 13814 | 0.070 |
Why?
|
| Feeding Behavior | 3 | 2015 | 3187 | 0.070 |
Why?
|
| Mosaicism | 1 | 2010 | 440 | 0.070 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2019 | 1679 | 0.070 |
Why?
|
| Marital Status | 1 | 2008 | 437 | 0.070 |
Why?
|
| Jejunum | 1 | 2009 | 480 | 0.070 |
Why?
|
| Sex Characteristics | 4 | 2010 | 2585 | 0.070 |
Why?
|
| Health Planning Guidelines | 1 | 2007 | 163 | 0.070 |
Why?
|
| Intestinal Mucosa | 2 | 2016 | 3038 | 0.070 |
Why?
|
| Reimbursement Mechanisms | 2 | 2009 | 670 | 0.070 |
Why?
|
| Subcutaneous Fat | 1 | 2009 | 391 | 0.070 |
Why?
|
| Beverages | 1 | 2011 | 820 | 0.070 |
Why?
|
| Body Temperature | 1 | 2009 | 776 | 0.070 |
Why?
|
| Adiponectin | 1 | 2012 | 1099 | 0.070 |
Why?
|
| Vital Capacity | 1 | 2008 | 922 | 0.070 |
Why?
|
| Adipose Tissue | 5 | 2010 | 3278 | 0.070 |
Why?
|
| Neuropeptides | 2 | 2008 | 942 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2014 | 2211 | 0.070 |
Why?
|
| Enteral Nutrition | 1 | 2011 | 763 | 0.070 |
Why?
|
| Hepatitis C, Chronic | 1 | 2014 | 1027 | 0.070 |
Why?
|
| Comorbidity | 2 | 2011 | 10372 | 0.070 |
Why?
|
| Receptor, Melanocortin, Type 1 | 1 | 2005 | 76 | 0.060 |
Why?
|
| Overweight | 2 | 2018 | 2366 | 0.060 |
Why?
|
| Prospective Studies | 8 | 2021 | 53187 | 0.060 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 1477 | 0.060 |
Why?
|
| MEDLINE | 1 | 2005 | 125 | 0.060 |
Why?
|
| Lisinopril | 1 | 2004 | 54 | 0.060 |
Why?
|
| Computational Biology | 3 | 2011 | 3518 | 0.060 |
Why?
|
| High Mobility Group Proteins | 1 | 2005 | 187 | 0.060 |
Why?
|
| Pain Threshold | 2 | 2005 | 585 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 3839 | 0.060 |
Why?
|
| Osteoporosis | 1 | 2014 | 1581 | 0.060 |
Why?
|
| Bone Diseases, Developmental | 1 | 2005 | 130 | 0.060 |
Why?
|
| Alternative Splicing | 1 | 2009 | 1118 | 0.060 |
Why?
|
| Prosthesis Implantation | 1 | 2009 | 641 | 0.060 |
Why?
|
| Safety | 1 | 2009 | 1185 | 0.060 |
Why?
|
| Databases, Genetic | 1 | 2011 | 1780 | 0.060 |
Why?
|
| Exons | 1 | 2010 | 2431 | 0.060 |
Why?
|
| Sciatica | 1 | 2004 | 98 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2016 | 8297 | 0.060 |
Why?
|
| Digestive System Physiological Phenomena | 1 | 2003 | 16 | 0.060 |
Why?
|
| United States | 7 | 2017 | 69693 | 0.060 |
Why?
|
| Receptors, Corticotropin | 1 | 2003 | 25 | 0.060 |
Why?
|
| Retrospective Studies | 4 | 2018 | 77098 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 3915 | 0.060 |
Why?
|
| Gastrectomy | 2 | 2023 | 652 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2005 | 438 | 0.060 |
Why?
|
| Catheterization | 1 | 2009 | 1468 | 0.060 |
Why?
|
| Mice, Knockout | 3 | 2015 | 14554 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 4 | 2019 | 5385 | 0.060 |
Why?
|
| Pedigree | 2 | 2010 | 4646 | 0.060 |
Why?
|
| Carotenoids | 3 | 1990 | 624 | 0.050 |
Why?
|
| Evidence-Based Medicine | 4 | 2021 | 3611 | 0.050 |
Why?
|
| Advisory Committees | 1 | 2007 | 773 | 0.050 |
Why?
|
| Appetite Regulation | 1 | 2003 | 88 | 0.050 |
Why?
|
| Liver Neoplasms | 2 | 2014 | 4249 | 0.050 |
Why?
|
| Pituitary Neoplasms | 1 | 1991 | 1340 | 0.050 |
Why?
|
| RNA, Messenger | 7 | 2012 | 13029 | 0.050 |
Why?
|
| Coronary Artery Disease | 3 | 2011 | 6454 | 0.050 |
Why?
|
| Nucleic Acid Conformation | 2 | 2011 | 914 | 0.050 |
Why?
|
| Fermentation | 2 | 1992 | 143 | 0.050 |
Why?
|
| Employment | 1 | 2008 | 1124 | 0.050 |
Why?
|
| Injections, Subcutaneous | 1 | 2023 | 664 | 0.050 |
Why?
|
| Lipid Metabolism | 1 | 2010 | 1887 | 0.050 |
Why?
|
| Age of Onset | 1 | 2008 | 3266 | 0.050 |
Why?
|
| Gene Expression | 3 | 2012 | 7790 | 0.050 |
Why?
|
| Patient Selection | 3 | 2016 | 4214 | 0.050 |
Why?
|
| Patient Compliance | 2 | 2008 | 2680 | 0.050 |
Why?
|
| Aged | 15 | 2023 | 162944 | 0.050 |
Why?
|
| Leukocytes | 1 | 2009 | 2039 | 0.050 |
Why?
|
| Longevity | 1 | 2009 | 1069 | 0.050 |
Why?
|
| Estrogens | 1 | 1988 | 1562 | 0.050 |
Why?
|
| Patient Care Team | 3 | 2010 | 2527 | 0.050 |
Why?
|
| Appetite | 1 | 2003 | 243 | 0.050 |
Why?
|
| DNA Mutational Analysis | 1 | 2010 | 4187 | 0.050 |
Why?
|
| Insulin-Secreting Cells | 1 | 2008 | 891 | 0.050 |
Why?
|
| Risk Assessment | 4 | 2021 | 23320 | 0.050 |
Why?
|
| Thymine | 2 | 1991 | 68 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2023 | 778 | 0.050 |
Why?
|
| Thymidine | 2 | 1991 | 309 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 3 | 2010 | 1342 | 0.050 |
Why?
|
| Organ Specificity | 3 | 2011 | 2003 | 0.050 |
Why?
|
| Physicians | 2 | 2018 | 4554 | 0.050 |
Why?
|
| Genome, Human | 2 | 2010 | 4420 | 0.050 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2021 | 187 | 0.050 |
Why?
|
| Family | 1 | 2011 | 3144 | 0.050 |
Why?
|
| Adolescent | 13 | 2023 | 85649 | 0.050 |
Why?
|
| Estrus | 2 | 1991 | 82 | 0.050 |
Why?
|
| Adenoma | 1 | 1991 | 2168 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2008 | 2260 | 0.040 |
Why?
|
| Transcription Factors | 3 | 2010 | 12164 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2014 | 20086 | 0.040 |
Why?
|
| Mitochondria | 1 | 2012 | 3520 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2015 | 3731 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1991 | 1374 | 0.040 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 1999 | 26 | 0.040 |
Why?
|
| Syndrome | 3 | 2008 | 3248 | 0.040 |
Why?
|
| Growth Charts | 1 | 2019 | 61 | 0.040 |
Why?
|
| Lipids | 1 | 2010 | 3302 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2005 | 1679 | 0.040 |
Why?
|
| Weight-Bearing | 1 | 2021 | 514 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2011 | 3294 | 0.040 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 15530 | 0.040 |
Why?
|
| Hospitalization | 1 | 2018 | 10232 | 0.040 |
Why?
|
| Rats, Inbred Strains | 2 | 1991 | 2191 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6534 | 0.040 |
Why?
|
| Drug Approval | 1 | 2005 | 740 | 0.040 |
Why?
|
| Autistic Disorder | 1 | 2008 | 1174 | 0.040 |
Why?
|
| Liver Cirrhosis | 2 | 1998 | 1864 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 1991 | 4147 | 0.040 |
Why?
|
| Growth Hormone | 2 | 1991 | 703 | 0.040 |
Why?
|
| Virus Replication | 2 | 1999 | 2531 | 0.040 |
Why?
|
| Phenotype | 6 | 2010 | 16331 | 0.040 |
Why?
|
| Receptors, Leptin | 1 | 2019 | 356 | 0.040 |
Why?
|
| Respiratory Mechanics | 2 | 1998 | 681 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 1991 | 3843 | 0.040 |
Why?
|
| Mitoguazone | 1 | 1997 | 10 | 0.040 |
Why?
|
| Lung Volume Measurements | 1 | 1998 | 377 | 0.040 |
Why?
|
| Cell Movement | 1 | 2009 | 5212 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 1999 | 1159 | 0.040 |
Why?
|
| Hyperplasia | 2 | 1991 | 1183 | 0.040 |
Why?
|
| Case-Control Studies | 6 | 2021 | 21719 | 0.040 |
Why?
|
| Cholestasis | 1 | 2000 | 378 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 2004 | 1359 | 0.040 |
Why?
|
| Microscopy, Electron | 2 | 1991 | 2645 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2005 | 1581 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2009 | 3455 | 0.040 |
Why?
|
| COS Cells | 1 | 1999 | 1160 | 0.040 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1998 | 381 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 24913 | 0.040 |
Why?
|
| Preoperative Care | 2 | 2016 | 2245 | 0.040 |
Why?
|
| Time Factors | 3 | 2017 | 40054 | 0.030 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2004 | 941 | 0.030 |
Why?
|
| Swine | 2 | 2021 | 5934 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2004 | 1606 | 0.030 |
Why?
|
| Child | 6 | 2019 | 77478 | 0.030 |
Why?
|
| Vitamin E | 2 | 1990 | 869 | 0.030 |
Why?
|
| Prognosis | 3 | 2015 | 29010 | 0.030 |
Why?
|
| Spirometry | 1 | 1998 | 862 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 1999 | 1202 | 0.030 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 2001 | 1379 | 0.030 |
Why?
|
| Genome, Viral | 1 | 1999 | 667 | 0.030 |
Why?
|
| Receptor, IGF Type 1 | 1 | 1997 | 390 | 0.030 |
Why?
|
| Hypothalamus | 2 | 1991 | 1063 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 2837 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2004 | 2043 | 0.030 |
Why?
|
| Reference Values | 3 | 2005 | 4982 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 1999 | 6608 | 0.030 |
Why?
|
| Universities | 1 | 2020 | 953 | 0.030 |
Why?
|
| Life Expectancy | 1 | 2021 | 1183 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 1998 | 1141 | 0.030 |
Why?
|
| Echocardiography | 2 | 1998 | 5097 | 0.030 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2006 | 1808 | 0.030 |
Why?
|
| Infusions, Intravenous | 2 | 2015 | 2271 | 0.030 |
Why?
|
| Mutation | 3 | 1999 | 29717 | 0.030 |
Why?
|
| Surgical Instruments | 1 | 2016 | 394 | 0.030 |
Why?
|
| Cardiovascular Diseases | 4 | 2016 | 15108 | 0.030 |
Why?
|
| Exercise Tolerance | 1 | 1998 | 770 | 0.030 |
Why?
|
| Methylnitronitrosoguanidine | 1 | 1992 | 20 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 2 | 2008 | 4801 | 0.030 |
Why?
|
| Methylnitrosourea | 1 | 1992 | 29 | 0.030 |
Why?
|
| International Cooperation | 1 | 2020 | 1421 | 0.030 |
Why?
|
| Prediabetic State | 1 | 2018 | 493 | 0.030 |
Why?
|
| Food | 1 | 1998 | 769 | 0.030 |
Why?
|
| Pneumocystis | 1 | 1992 | 57 | 0.030 |
Why?
|
| Research Design | 1 | 2009 | 5979 | 0.030 |
Why?
|
| Echinocandins | 1 | 1992 | 44 | 0.030 |
Why?
|
| Hepatitis Antibodies | 1 | 1992 | 73 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2021 | 9941 | 0.030 |
Why?
|
| Viral Hepatitis Vaccines | 1 | 1993 | 80 | 0.030 |
Why?
|
| Hepatitis C Antibodies | 1 | 1992 | 145 | 0.030 |
Why?
|
| Genetic Variation | 2 | 2005 | 6540 | 0.030 |
Why?
|
| Knee Joint | 1 | 2021 | 1679 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3920 | 0.030 |
Why?
|
| Watchful Waiting | 1 | 2017 | 491 | 0.030 |
Why?
|
| Alleles | 3 | 2011 | 6931 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2005 | 3391 | 0.030 |
Why?
|
| Hepatitis B Antibodies | 1 | 1992 | 159 | 0.030 |
Why?
|
| Rheumatoid Factor | 1 | 1992 | 188 | 0.030 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2012 | 92 | 0.030 |
Why?
|
| Bone Remodeling | 1 | 2016 | 575 | 0.030 |
Why?
|
| Microbiological Techniques | 1 | 1992 | 102 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 4751 | 0.030 |
Why?
|
| Citric Acid Cycle | 1 | 2012 | 231 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 1788 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 5133 | 0.030 |
Why?
|
| Sodium Glutamate | 1 | 1991 | 27 | 0.030 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 1992 | 305 | 0.020 |
Why?
|
| Laparoscopy | 2 | 2016 | 2121 | 0.020 |
Why?
|
| Castration | 1 | 1991 | 158 | 0.020 |
Why?
|
| Reproducibility of Results | 4 | 2010 | 19862 | 0.020 |
Why?
|
| Peptide YY | 1 | 2011 | 130 | 0.020 |
Why?
|
| Kinetics | 1 | 1999 | 6474 | 0.020 |
Why?
|
| Molecular Weight | 2 | 1991 | 2255 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2018 | 3913 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1999 | 6313 | 0.020 |
Why?
|
| Mice, Mutant Strains | 2 | 2005 | 1866 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2015 | 934 | 0.020 |
Why?
|
| Pituitary Gland, Posterior | 1 | 1990 | 43 | 0.020 |
Why?
|
| Median Eminence | 1 | 1990 | 37 | 0.020 |
Why?
|
| Cause of Death | 1 | 2021 | 3571 | 0.020 |
Why?
|
| Lipoproteins | 1 | 2015 | 876 | 0.020 |
Why?
|
| Oxidative Phosphorylation | 1 | 2012 | 480 | 0.020 |
Why?
|
| Internationality | 1 | 2016 | 1002 | 0.020 |
Why?
|
| Sulfides | 1 | 1991 | 166 | 0.020 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2010 | 65 | 0.020 |
Why?
|
| Peptides, Cyclic | 1 | 1992 | 401 | 0.020 |
Why?
|
| Heart Rate | 2 | 1998 | 4091 | 0.020 |
Why?
|
| Antiviral Agents | 2 | 1993 | 2978 | 0.020 |
Why?
|
| Digestive System | 2 | 1988 | 251 | 0.020 |
Why?
|
| Hypertension | 2 | 2015 | 8455 | 0.020 |
Why?
|
| Biliopancreatic Diversion | 1 | 2010 | 16 | 0.020 |
Why?
|
| Floxuridine | 1 | 1989 | 47 | 0.020 |
Why?
|
| Heterocyclic Compounds | 1 | 1991 | 249 | 0.020 |
Why?
|
| Aftercare | 1 | 2016 | 860 | 0.020 |
Why?
|
| Protein Phosphatase 1 | 1 | 2010 | 137 | 0.020 |
Why?
|
| Binding Sites | 1 | 1999 | 6115 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2015 | 1438 | 0.020 |
Why?
|
| Food Analysis | 1 | 1990 | 104 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2004 | 3336 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2010 | 323 | 0.020 |
Why?
|
| Mortality | 1 | 2021 | 2857 | 0.020 |
Why?
|
| Candida albicans | 1 | 1992 | 394 | 0.020 |
Why?
|
| Carcinoid Tumor | 1 | 1991 | 235 | 0.020 |
Why?
|
| Thiazolidinediones | 1 | 2012 | 476 | 0.020 |
Why?
|
| Zidovudine | 1 | 1991 | 620 | 0.020 |
Why?
|
| Pain Measurement | 2 | 2012 | 3418 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2010 | 424 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1991 | 1581 | 0.020 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2009 | 154 | 0.020 |
Why?
|
| Hair Color | 2 | 2005 | 136 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 1990 | 862 | 0.020 |
Why?
|
| Parathyroid Hormone | 1 | 2016 | 1801 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 2906 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 7901 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2016 | 1503 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1992 | 1574 | 0.020 |
Why?
|
| Molecular Biology | 1 | 1993 | 595 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1998 | 1847 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 2915 | 0.020 |
Why?
|
| Patient Education as Topic | 2 | 2009 | 2275 | 0.020 |
Why?
|
| Golgi Apparatus | 1 | 1990 | 410 | 0.020 |
Why?
|
| Atherosclerosis | 2 | 2018 | 3428 | 0.020 |
Why?
|
| Prader-Willi Syndrome | 1 | 1989 | 79 | 0.020 |
Why?
|
| Models, Biological | 2 | 2009 | 9581 | 0.020 |
Why?
|
| Chromosome Deletion | 2 | 1990 | 1400 | 0.020 |
Why?
|
| Combined Modality Therapy | 2 | 2016 | 8621 | 0.020 |
Why?
|
| Peptide Biosynthesis | 1 | 1988 | 55 | 0.020 |
Why?
|
| Gastroplasty | 1 | 2010 | 140 | 0.020 |
Why?
|
| Nutrition Assessment | 1 | 2011 | 723 | 0.020 |
Why?
|
| Streptozocin | 2 | 1998 | 193 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2001 | 11472 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2003 | 4229 | 0.020 |
Why?
|
| Body Size | 1 | 2010 | 461 | 0.020 |
Why?
|
| Cytoplasmic Granules | 1 | 1990 | 610 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2016 | 1368 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3862 | 0.020 |
Why?
|
| Mutagenesis | 1 | 1991 | 1263 | 0.020 |
Why?
|
| Infant | 2 | 2019 | 35070 | 0.020 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1995 | 1130 | 0.020 |
Why?
|
| Molecular Structure | 1 | 1991 | 1907 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 1991 | 1802 | 0.020 |
Why?
|
| Acanthosis Nigricans | 1 | 2006 | 48 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1990 | 1799 | 0.020 |
Why?
|
| Pyridones | 1 | 1991 | 712 | 0.020 |
Why?
|
| Central Nervous System Diseases | 1 | 1991 | 518 | 0.020 |
Why?
|
| Medically Underserved Area | 1 | 2009 | 253 | 0.020 |
Why?
|
| Oxygen | 1 | 1998 | 4169 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 12773 | 0.020 |
Why?
|
| Introns | 1 | 2009 | 991 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2008 | 326 | 0.020 |
Why?
|
| Sweden | 1 | 2009 | 1343 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1988 | 1086 | 0.020 |
Why?
|
| Cholesterol | 1 | 2015 | 2895 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 12344 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2012 | 995 | 0.020 |
Why?
|
| Health Policy | 2 | 2009 | 2657 | 0.020 |
Why?
|
| Glycosylation | 1 | 2009 | 1123 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 18006 | 0.020 |
Why?
|
| Genetic Markers | 2 | 2009 | 2633 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6483 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 1991 | 2187 | 0.020 |
Why?
|
| Disease Management | 1 | 2017 | 2450 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1990 | 2335 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 1998 | 3656 | 0.020 |
Why?
|
| Disease | 1 | 2011 | 681 | 0.020 |
Why?
|
| Morphine Derivatives | 1 | 2005 | 44 | 0.020 |
Why?
|
| DNA | 2 | 2011 | 7289 | 0.020 |
Why?
|
| Stroke Volume | 1 | 1998 | 4983 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 15056 | 0.020 |
Why?
|
| Anti-HIV Agents | 1 | 2001 | 4250 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 2009 | 952 | 0.020 |
Why?
|
| Vincristine | 2 | 2001 | 1036 | 0.020 |
Why?
|
| Fluorouracil | 1 | 1989 | 1615 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 1991 | 2024 | 0.020 |
Why?
|
| Chromosome Breakage | 1 | 2005 | 173 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 1989 | 1465 | 0.020 |
Why?
|
| Hemodynamics | 1 | 1995 | 4197 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2005 | 39004 | 0.020 |
Why?
|
| beta Carotene | 3 | 1990 | 527 | 0.020 |
Why?
|
| SOX9 Transcription Factor | 1 | 2005 | 146 | 0.020 |
Why?
|
| Medicaid | 1 | 2017 | 2716 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2016 | 3740 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1988 | 981 | 0.010 |
Why?
|
| Neutropenia | 2 | 2001 | 891 | 0.010 |
Why?
|
| Specialization | 1 | 2009 | 777 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2011 | 3587 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2019 | 7716 | 0.010 |
Why?
|
| Prevalence | 2 | 2012 | 15194 | 0.010 |
Why?
|
| Pentazocine | 1 | 2003 | 13 | 0.010 |
Why?
|
| Maprotiline | 1 | 1983 | 4 | 0.010 |
Why?
|
| Receptors, Melanocortin | 1 | 2003 | 25 | 0.010 |
Why?
|
| Europe | 1 | 2010 | 3339 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 7770 | 0.010 |
Why?
|
| Protein Precursors | 1 | 1988 | 1154 | 0.010 |
Why?
|
| Genomics | 1 | 2019 | 5692 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1991 | 5180 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 1998 | 2410 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 1983 | 295 | 0.010 |
Why?
|
| Nutrition Surveys | 1 | 1990 | 1656 | 0.010 |
Why?
|
| Anthracenes | 1 | 1983 | 84 | 0.010 |
Why?
|
| Neoplasms | 2 | 2011 | 21596 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 1990 | 1416 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2009 | 2713 | 0.010 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2006 | 369 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1991 | 2231 | 0.010 |
Why?
|
| Prosthesis Design | 1 | 2009 | 2110 | 0.010 |
Why?
|
| Lymphoma | 1 | 1991 | 1873 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2003 | 642 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 1997 | 11363 | 0.010 |
Why?
|
| Body Composition | 1 | 2011 | 2400 | 0.010 |
Why?
|
| Adenoviruses, Human | 1 | 1983 | 257 | 0.010 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2003 | 144 | 0.010 |
Why?
|
| Pressure | 1 | 2005 | 1203 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1983 | 1094 | 0.010 |
Why?
|
| Prostheses and Implants | 1 | 2009 | 1385 | 0.010 |
Why?
|
| Stavudine | 1 | 2001 | 85 | 0.010 |
Why?
|
| Indinavir | 1 | 2001 | 74 | 0.010 |
Why?
|
| Antineoplastic Agents | 2 | 1997 | 13655 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2011 | 5454 | 0.010 |
Why?
|
| Child, Preschool | 3 | 1999 | 40955 | 0.010 |
Why?
|
| Cyclophosphamide | 2 | 2001 | 2236 | 0.010 |
Why?
|
| Exercise | 1 | 2017 | 5611 | 0.010 |
Why?
|
| Primates | 1 | 1983 | 543 | 0.010 |
Why?
|
| Estradiol | 1 | 1988 | 2021 | 0.010 |
Why?
|
| Morphine | 1 | 2005 | 657 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2005 | 10943 | 0.010 |
Why?
|
| Biopsy | 1 | 2012 | 6756 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 3847 | 0.010 |
Why?
|
| Tachycardia | 1 | 1983 | 620 | 0.010 |
Why?
|
| Doxorubicin | 2 | 2001 | 2215 | 0.010 |
Why?
|
| Medicine | 1 | 2009 | 941 | 0.010 |
Why?
|
| Polysomnography | 1 | 2006 | 1772 | 0.010 |
Why?
|
| Lamivudine | 1 | 2001 | 342 | 0.010 |
Why?
|
| Anorexia | 1 | 2000 | 159 | 0.010 |
Why?
|
| Metformin | 1 | 2006 | 829 | 0.010 |
Why?
|
| Medicare | 1 | 2017 | 6532 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 1983 | 1034 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2005 | 1417 | 0.010 |
Why?
|
| Drinking | 1 | 2000 | 197 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2019 | 25575 | 0.010 |
Why?
|
| Work of Breathing | 1 | 1998 | 49 | 0.010 |
Why?
|
| Anaerobic Threshold | 1 | 1998 | 52 | 0.010 |
Why?
|
| Critical Care | 1 | 2011 | 2640 | 0.010 |
Why?
|
| Epididymis | 1 | 2000 | 227 | 0.010 |
Why?
|
| Survivors | 1 | 2009 | 2286 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2008 | 2556 | 0.010 |
Why?
|
| Aspirin | 1 | 1990 | 3278 | 0.010 |
Why?
|
| Perception | 1 | 2005 | 1188 | 0.010 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2001 | 647 | 0.010 |
Why?
|
| Animal Feed | 1 | 1998 | 110 | 0.010 |
Why?
|
| Analgesics, Opioid | 2 | 2005 | 3667 | 0.010 |
Why?
|
| Radiography | 1 | 2009 | 7010 | 0.010 |
Why?
|
| Dexamethasone | 2 | 1998 | 1949 | 0.010 |
Why?
|
| Immunotherapy | 1 | 1993 | 4414 | 0.010 |
Why?
|
| Acute Disease | 2 | 2000 | 7141 | 0.010 |
Why?
|
| Corticosterone | 1 | 1998 | 310 | 0.010 |
Why?
|
| Risk | 1 | 2009 | 9679 | 0.010 |
Why?
|
| Prednisone | 1 | 2001 | 1567 | 0.010 |
Why?
|
| Ischemia | 1 | 2005 | 1911 | 0.010 |
Why?
|
| Massachusetts | 1 | 2009 | 8662 | 0.010 |
Why?
|
| Adrenalectomy | 1 | 1998 | 342 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1997 | 1101 | 0.010 |
Why?
|
| Quality of Life | 1 | 2017 | 12730 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1997 | 433 | 0.010 |
Why?
|
| Radiation Tolerance | 1 | 1997 | 484 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 1983 | 2440 | 0.010 |
Why?
|
| HIV Infections | 1 | 2001 | 16678 | 0.010 |
Why?
|
| Barium Sulfate | 1 | 1995 | 180 | 0.010 |
Why?
|
| Enema | 1 | 1995 | 141 | 0.010 |
Why?
|
| Sigmoidoscopy | 1 | 1995 | 156 | 0.010 |
Why?
|
| Age Factors | 1 | 2010 | 18355 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1983 | 2267 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 9639 | 0.010 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2001 | 1872 | 0.010 |
Why?
|
| Viral Load | 1 | 2001 | 3292 | 0.010 |
Why?
|
| Mastectomy, Segmental | 1 | 1997 | 955 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 1997 | 1769 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1998 | 1869 | 0.010 |
Why?
|
| Melanoma | 1 | 1990 | 5462 | 0.010 |
Why?
|
| Thromboxane B2 | 1 | 1990 | 152 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2000 | 3199 | 0.010 |
Why?
|
| Bleomycin | 1 | 1991 | 499 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 1997 | 20774 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1990 | 878 | 0.010 |
Why?
|
| Leucovorin | 1 | 1991 | 624 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1983 | 6440 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1990 | 768 | 0.010 |
Why?
|
| Angiography | 1 | 1995 | 1636 | 0.010 |
Why?
|
| Densitometry | 1 | 1989 | 156 | 0.010 |
Why?
|
| Transfection | 1 | 1997 | 5892 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 1997 | 1171 | 0.010 |
Why?
|
| Gastrin-Releasing Peptide | 1 | 1988 | 38 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1997 | 4929 | 0.010 |
Why?
|
| Receptors, Bombesin | 1 | 1988 | 27 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2000 | 4414 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 1998 | 2107 | 0.010 |
Why?
|
| Opportunistic Infections | 1 | 1991 | 389 | 0.000 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1988 | 178 | 0.000 |
Why?
|
| DNA Probes | 1 | 1989 | 560 | 0.000 |
Why?
|
| Data Interpretation, Statistical | 1 | 1998 | 2714 | 0.000 |
Why?
|
| Colonoscopy | 1 | 1995 | 1365 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1991 | 13019 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1983 | 9274 | 0.000 |
Why?
|
| Colitis, Ulcerative | 1 | 1998 | 1901 | 0.000 |
Why?
|
| Young Adult | 1 | 2012 | 56350 | 0.000 |
Why?
|
| HIV Seropositivity | 1 | 1991 | 970 | 0.000 |
Why?
|
| Crohn Disease | 1 | 1998 | 2301 | 0.000 |
Why?
|
| Chronic Disease | 1 | 2000 | 9144 | 0.000 |
Why?
|
| Recurrence | 1 | 1997 | 8333 | 0.000 |
Why?
|
| Methotrexate | 1 | 1991 | 1720 | 0.000 |
Why?
|
| Survival Analysis | 1 | 1997 | 10248 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1983 | 918 | 0.000 |
Why?
|
| Precipitin Tests | 1 | 1983 | 829 | 0.000 |
Why?
|
| Chromatography, Affinity | 1 | 1983 | 549 | 0.000 |
Why?
|
| Cell Transformation, Viral | 1 | 1983 | 565 | 0.000 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 1997 | 5163 | 0.000 |
Why?
|
| Iron | 1 | 1990 | 1773 | 0.000 |
Why?
|
| Thyroid Gland | 1 | 1988 | 1172 | 0.000 |
Why?
|
| Central Nervous System | 1 | 1988 | 1354 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1990 | 6452 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1997 | 9185 | 0.000 |
Why?
|
| Aged, 80 and over | 2 | 1995 | 57683 | 0.000 |
Why?
|
| Odds Ratio | 1 | 1990 | 9846 | 0.000 |
Why?
|
| Alcohol Drinking | 1 | 1990 | 3957 | 0.000 |
Why?
|
| Thyroid Neoplasms | 1 | 1988 | 2274 | 0.000 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1983 | 2948 | 0.000 |
Why?
|
| Smoking | 1 | 1990 | 8969 | 0.000 |
Why?
|
| Lung | 1 | 1988 | 9826 | 0.000 |
Why?
|
| Cell Line | 1 | 1983 | 15994 | 0.000 |
Why?
|